Pfizer has now announced that it intends to sell Comirnaty for between $110 and $130 per dose – roughly four times the current price, and 100 times The People’s Vaccine Alliance’s estimated ...

The drug will be made available to people with private health insurance from the start of next year, said Pfizer. Comirnaty sales, meanwhile, are expected to be around $2 billion lower than ...

British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory ...

United States health authorities Monday gave full approval to the COVID-19 vaccine developed by Pfizer-BioNTech, which will now be marketed under the Comirnaty brand. Moderna's drug is expected to ...

In a year in which he faced down a challenge from an activist investor, Pfizer CEO Albert Bourla ... the plummeting demand for its COVID vaccine Comirnaty and COVID antiviral Paxlovid, Bourla ...